DOW increases global capacity for solid pharma grade PEGs
In response to growing global demand for its products, Dow Chemical Co plans a 30% increase in production capacity for its solid grade Carbowax Sentry polyethylene glycols (PEG).
In response to growing global demand for its products, Dow Chemical Co plans a 30% increase in production capacity for its solid grade Carbowax Sentry polyethylene glycols (PEG).
The extra capacity will be provided by the St Charles Operations manufacturing facility, located in Hahnville, Louisiana, by the end of 2008.
Carbowax Sentry PEGs are produced to meet the high quality requirements of pharmaceutical, food and personal care applications. Pharma uses include the production of active pharmaceutical ingredients as well as excipients such as tablet binders, plasticizers and carriers. The materials are made under strict GMP compliance and meet United States and European Pharmacopeia requirements.
